Pregled bibliografske jedinice broj: 550167
Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A
Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A // Neuroscience, 186 (2011), 201-207 doi:10.1016/j.neuroscience.2011.04.026 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 550167 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A
Autori
Matak, Ivica ; Bach-Rojecky, Lidija ; Filipović, Boris ; Lacković, Zdravko
Izvornik
Neuroscience (0306-4522) 186
(2011);
201-207
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
axonal transport; botulinum toxin A; synaptosomal associated protein 25; antinociceptive activity; sensory neurons
Sažetak
Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic hyperactivity disorders, and, recently, migraine headache. Although suggested to act only locally, novel observations demonstrated bilateral reduction of pain after unilateral toxin injection, and proposed retrograde axonal transport, presumably in sensory neurons. However, up to now, axonal transport of BTX-A from periphery to CNS was identified only in motoneurons, but with unknown significance. We assessed the effects of low doses of BTX-A injected into the rat whisker pad (3.5 U/kg) or into the sensory trigeminal ganglion (1 U/kg) on formalin-induced facial pain. Axonal transport was prevented by colchicine injection into the trigeminal ganglion (5 mM, 2 μl). To find the possible site of action of axonally transported BTX-A, we employed immunohistochemical labeling of BTX-A-truncated synaptosomal-associated protein 25 (SNAP-25) in medullary dorsal horn of trigeminal nucleus caudalis after toxin injection into the whisker pad. Both peripheral and intraganglionic BTX-A reduce phase II of formalin-induced pain. Antinociceptive effect of BTX-A was prevented completely by colchicine. BTX-A-truncated SNAP-25 in medullary dorsal horn (spinal trigeminal nucleus) was evident 3 days following the peripheral treatment, even with low dose applied (3.5 U/kg). Presented data provide the first evidence that axonal transport of BTX-A, obligatory for its antinociceptive effects, occurs via sensory neurons and is directed to sensory nociceptive nuclei in the CNS.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
108-1080003-0001 - NEUROTRANSMITORI I NOVI MEHANIZMI DJELOVANJA LIJEKOVA I OTROVA (Lackovic, Zdravko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Zdravko Lacković
(autor)
Lidija Bach Rojecky
(autor)
Ivica Matak
(autor)
Boris Filipović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE